This medication is an aminoglycoside antibiotic, prescribed for the management of cystic fibrosis. It eliminates bacteria that cause many kinds of infections.
IV/IM- The recommended dosage for both adults and pediatric patients 6 years of age and older is 1 single-use ampule (300 mg) administered two times per day for 28 days.
Capsule- 28 mg twice daily for 28 days using the Podhaler device.
It comes as a solution for injection to be administered by a healthcare provider either into the vein or into a large muscle.
It is also available in solution and powder form (for oral inhalation). Inhale as directed by your physician.
Caution should be exercised in patients with history of myasthenia gravis, Parkinson disease, hearing, nerve or kidney problems, burns, dehydration, low blood minerals, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding.
It may lead to dehydration, drink adequate fluid.
Avoid long-term use of this medication; otherwise it will cause secondary infection.
Take full course of treatment and avoid excess dosage.
Monitor kidney function, hearing tests, blood electrolyte levels regularly while taking this medication.
Increased cough, inflammation of pharynx, sputum, nose inflammation, difficulty in breathing, lung disorder, asthma, nosebleed and over breathing.
Central Nervous System: Increased weakness, fever, headache, uneasiness and dizziness.
Heart: Chest pain.
Gastrointestinal: Loss of appetite, nausea, vomiting, abdominal pain, diarrhea and weight loss.
ENT: Voice alteration, ear pain, taste perversion and nose inflammation.
Miscellaneous: Back pain and rash.
Avoid immunizations/vaccinations while using this medication.
Store it in refrigerator (2-8ēC), and in an airtight container. Do not freeze it.
Proper understanding of waste collection, segregation and management is required to reduce the ...
Leukoplakia refers to a painless, raised white patch in the mouth that does not go away on rubbing, ...
Health insurance has emerged one of the fastest growing segments in the non-life insurance industry ...View All